We provide insights on latest assessments in biosafety, biosecurity and responsible bioscience to stakeholders and the interested public.

C1 C2 C3 C4 C5 C6

Environmental risk assessment of gene therapy
products and recombinant vaccines

  • Synthetic Biology: new risks and new regulations? U. Jenal, Swiss Expert Committee for Biosafety, 2016, Bern

  • Risk Assessment of Synthetic Biology, U. Jenal, European Society for Gene and Cell Therapy Conferences, Madrid, Spain, October 2012 and Helsinki, Finland, September 2015

  • Ist Synthetischen Biologie die sichere Biotechnologie?, U. Jenal, Workshop on Synthetic Biology by TA-Swiss, March 2015, Bern, Switzerland

  • Synthetic Biology Website of the Swiss Academy of Science, participation in site development regarding Safety, Regulatory Requirements, Examples, Forum for Genetic Research, 2015, Bern, Switzerland

  • Environmental Risk Assessment of Gene Therapy Products, U. Jenal, DECHEMA Course on ATMPs, November 2015, Tutzing, Germany

  • Environmental Risk Assessment of Gene Therapy Products, U. Jenal, Swiss Biotech Association, Biotech Fall Day, October 2015, Monthey, Switzerland

  • Environmental Risk Assessment of Glybera, an AAV-based Gene Therapy Product, regarding the Authorisation of the Placing on the Market in Europe, U. Jenal, F.G.C. Salmon, Annual Conference of the American Biosafety Association, October 2014, ABSA, San Diego, USA

  • Production and application of nano-bio-objects the crossroad of nano-bio risk management, U. Jenal, European Biosafety Association Annual Conference, April 2011, Estoril, Portugal

  • Production and application of BioNanoParticles: the crossroad of chemistry, biotechnology and medicines regulations, U. Jenal, 1st International Congress BioNanoMed 2009, Nanotechnology in Medicine & Biology, Krems, Austria

Biorisk management advisors as gatekeepers of sustainable biotechnology

November 03 2021
Fostering biotechnology to achieve sustainable development goals needs sound biological risk assessment and mitigation to stay within the limits of safety and security of people and the environment.

Highlights of the World Vaccine Congress Europe 19-21 October 2021 in Barcelona

October 26 2021
Thanks to the tremendous efforts of Terrapinn UK the 2021 World Vaccine Congress Europe could take place on site. Highlights related to the COVID-19 pandemic and other vaccines are summarized below.

Gene technology for sustainable development

July 12 2021
Gene technology for sustainable development: a genetically modified Saccharomyces cerevisiae to produce ethanol from toxified lignocellulosic feedstocks
Go to Blog